IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 77 filers reported holding IGM BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,716 | -6.2% | 5,954 | +3.7% | 0.00% | – |
| Q2 2023 | $52,999 | -24.5% | 5,742 | +12.5% | 0.00% | – |
| Q1 2023 | $70,156 | -17.6% | 5,106 | +2.0% | 0.00% | -100.0% |
| Q4 2022 | $85,118 | -25.3% | 5,004 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $114,000 | +35.7% | 5,023 | +7.2% | 0.00% | 0.0% |
| Q2 2022 | $84,000 | -22.9% | 4,684 | +15.0% | 0.00% | 0.0% |
| Q1 2022 | $109,000 | -14.8% | 4,072 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $128,000 | -55.9% | 4,358 | -1.3% | 0.00% | -50.0% |
| Q3 2021 | $290,000 | -22.9% | 4,414 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $376,000 | +12.2% | 4,519 | +3.6% | 0.00% | 0.0% |
| Q1 2021 | $335,000 | -8.0% | 4,364 | +5.8% | 0.00% | 0.0% |
| Q4 2020 | $364,000 | +16.3% | 4,125 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $313,000 | -1.3% | 4,245 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $317,000 | +92.1% | 4,341 | +48.1% | 0.00% | +100.0% |
| Q1 2020 | $165,000 | +39.8% | 2,931 | -5.5% | 0.00% | – |
| Q4 2019 | $118,000 | – | 3,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |